gold_std_association_type	pubmed_id	num_sentence	subject_text	subject_start	subject_end	subject_type	object_text	object_start	object_end	object_type	original_sentence	formatted_sentence	form_subject	form_object
positive	17167348	11	spinal cord infarction	43	65	disease	cocaine	19	26	drug	Although uncommon, cocaine abuse can cause spinal cord infarction.	"<div class=""formatted_sentence"">Although uncommon, <span class=""object_text"">cocaine</span> abuse can cause <span class=""subject_text"">spinal cord infarction</span>.</div>"	"&quot;<span class=""form_subject"">spinal cord infarction</span>&quot;"	"&quot;<span class=""form_object"">cocaine</span>&quot;"
positive	18512713	8	melanoma	206	214	disease	methotrexate	59	71	drug	There was an estimated 50% excess risk of malignancy among methotrexate-exposed RA patients relative to the general population (SIR 1.5, 95% confidence interval [95% CI] 1.2-1.9), with a 3-fold increase in melanoma (SIR 3.0, 95% CI 1.2-6.2), a 5-fold increase in non-Hodgkin's lymphoma (SIR 5.1, 95% CI 2.2-10.0), and an almost 3-fold increase in lung cancer (SIR 2.9, 95% CI 1.6-4.8).	"<div class=""formatted_sentence"">There was an estimated 50% excess risk of malignancy among <span class=""object_text"">methotrexate</span>-exposed RA patients relative to the general population (SIR 1.5, 95% confidence interval [95% CI] 1.2-1.9), with a 3-fold increase in <span class=""subject_text"">melanoma</span> (SIR 3.0, 95% CI 1.2-6.2), a 5-fold increase in non-Hodgkin's lymphoma (SIR 5.1, 95% CI 2.2-10.0), and an almost 3-fold increase in lung cancer (SIR 2.9, 95% CI 1.6-4.8).</div>"	"&quot;<span class=""form_subject"">melanoma</span>&quot;"	"&quot;<span class=""form_object"">methotrexate</span>&quot;"
false	18058121	1	spontaneous abortions	97	118	disease	radioisotopes of metals and halogen elements	12	56	drug	Exposure to radioisotopes of metals and halogen elements occurring in medical practice may cause spontaneous abortions.	"<div class=""formatted_sentence"">Exposure to <span class=""object_text"">radioisotopes of metals and halogen elements</span> occurring in medical practice may cause <span class=""subject_text"">spontaneous abortions</span>.</div>"	"&quot;<span class=""form_subject"">spontaneous abortions</span>&quot;"	"&quot;<span class=""form_object"">radioisotopes of metals and halogen elements</span>&quot;"
false	17634547	13	tumor	87	92	disease	tibolone	31	39	drug	In ER+ breast tumors, 2.5 mg/d tibolone given for 14 days has no significant effect on tumor cell proliferation.	"<div class=""formatted_sentence"">In ER+ breast tumors, 2.5 mg/d <span class=""object_text"">tibolone</span> given for 14 days has no significant effect on <span class=""subject_text"">tumor</span> cell proliferation.</div>"	"&quot;<span class=""form_subject"">tumor</span>&quot;"	"&quot;<span class=""form_object"">tibolone</span>&quot;"
false	17894421	1	orofacial clefts	156	172	disease	Benzodiazepines	12	27	drug	Exposure to Benzodiazepines (BZD) during foetal life has been suggested to contribute to neonatal morbidity and some congenital malformations, for example, orofacial clefts.	"<div class=""formatted_sentence"">Exposure to <span class=""object_text"">Benzodiazepines</span> (BZD) during foetal life has been suggested to contribute to neonatal morbidity and some congenital malformations, for example, <span class=""subject_text"">orofacial clefts</span>.</div>"	"&quot;<span class=""form_subject"">orofacial clefts</span>&quot;"	"&quot;<span class=""form_object"">Benzodiazepines</span>&quot;"
positive	18713156	7	migraine headache	97	114	disease	topiramate	43	53	drug	This study demonstrated that both low-dose topiramate and propranolol could significantly reduce migraine headache frequency, intensity, and duration.	"<div class=""formatted_sentence"">This study demonstrated that both low-dose <span class=""object_text"">topiramate</span> and propranolol could significantly reduce <span class=""subject_text"">migraine headache</span> frequency, intensity, and duration.</div>"	"&quot;<span class=""form_subject"">migraine headache</span>&quot;"	"&quot;<span class=""form_object"">topiramate</span>&quot;"
false	17340045	9	noninfectious granulomatous syndromes	37	74	disease	etanercept	97	107	drug	Recently, there have been reports of noninfectious granulomatous syndromes in patients receiving etanercept for a variety of diseases.	"<div class=""formatted_sentence"">Recently, there have been reports of <span class=""subject_text"">noninfectious granulomatous syndromes</span> in patients receiving <span class=""object_text"">etanercept</span> for a variety of diseases.</div>"	"&quot;<span class=""form_subject"">noninfectious granulomatous syndromes</span>&quot;"	"&quot;<span class=""form_object"">etanercept</span>&quot;"
speculative	18452197	9	ulcerative colitis	214	232	disease	low-dose 5-ASA	24	38	drug	These data suggest that low-dose 5-ASA may be efficacious in preventing colitis-associated dysplasias and provide strong support for optimizing this therapy for the prevention of colonic neoplasms in patients with ulcerative colitis.	"<div class=""formatted_sentence"">These data suggest that <span class=""object_text"">low-dose 5-ASA</span> may be efficacious in preventing colitis-associated dysplasias and provide strong support for optimizing this therapy for the prevention of colonic neoplasms in patients with <span class=""subject_text"">ulcerative colitis</span>.</div>"	"&quot;<span class=""form_subject"">ulcerative colitis</span>&quot;"	"&quot;<span class=""form_object"">low-dose 5-ASA</span>&quot;"
false	18371953	4	glioma	138	144	disease	indomethacin-loaded nanocapsules	53	85	drug	The aim of this study was to evaluate the effects of indomethacin-loaded nanocapsules and indomethacin ethyl ester-loaded nanocapsules on glioma cell lines.	"<div class=""formatted_sentence"">The aim of this study was to evaluate the effects of <span class=""object_text"">indomethacin-loaded nanocapsules</span> and indomethacin ethyl ester-loaded nanocapsules on <span class=""subject_text"">glioma</span> cell lines.</div>"	"&quot;<span class=""form_subject"">glioma</span>&quot;"	"&quot;<span class=""form_object"">indomethacin-loaded nanocapsules</span>&quot;"
speculative	17340045	1	sarcoidosis	55	66	disease	etanercept	87	97	drug	We report two rheumatoid arthritis patients developing sarcoidosis possibly induced by etanercept.	"<div class=""formatted_sentence"">We report two rheumatoid arthritis patients developing <span class=""subject_text"">sarcoidosis</span> possibly induced by <span class=""object_text"">etanercept</span>.</div>"	"&quot;<span class=""form_subject"">sarcoidosis</span>&quot;"	"&quot;<span class=""form_object"">etanercept</span>&quot;"
false	18042885	0	Cardiovascular thromboembolic adverse effects	0	45	disease	cyclooxygenase	62	76	drug	Cardiovascular thromboembolic adverse effects associated with cyclooxygenase-2 selective inhibitors and nonselective antiinflammatory drugs.	"<div class=""formatted_sentence""><span class=""subject_text"">Cardiovascular thromboembolic adverse effects</span> associated with <span class=""object_text"">cyclooxygenase</span>-2 selective inhibitors and nonselective antiinflammatory drugs.</div>"	"&quot;<span class=""form_subject"">Cardiovascular thromboembolic adverse effects</span>&quot;"	"&quot;<span class=""form_object"">cyclooxygenase</span>&quot;"
positive	17697016	8	anaemia	47	54	disease	Zidovudine	0	10	drug	Zidovudine discontinuation could help to avoid anaemia associated with anti-HCV therapy.	"<div class=""formatted_sentence""><span class=""object_text"">Zidovudine</span> discontinuation could help to avoid <span class=""subject_text"">anaemia</span> associated with anti-HCV therapy.</div>"	"&quot;<span class=""form_subject"">anaemia</span>&quot;"	"&quot;<span class=""form_object"">Zidovudine</span>&quot;"
positive	18371953	7	glioma	193	199	disease	solution of indomethacin	114	138	drug	The main finding of the present study is that indomethacin-loaded nanocapsules formulation was more potent than a solution of indomethacin in decreasing the viability and cell proliferation of glioma lines.	"<div class=""formatted_sentence"">The main finding of the present study is that indomethacin-loaded nanocapsules formulation was more potent than a <span class=""object_text"">solution of indomethacin</span> in decreasing the viability and cell proliferation of <span class=""subject_text"">glioma</span> lines.</div>"	"&quot;<span class=""form_subject"">glioma</span>&quot;"	"&quot;<span class=""form_object"">solution of indomethacin</span>&quot;"
positive	18975369	6	gout flares	73	84	disease	allopurinol	137	148	drug	The primary reasons for withdrawal were similar across groups except for gout flares, which were more frequent with febuxostat than with allopurinol.	"<div class=""formatted_sentence"">The primary reasons for withdrawal were similar across groups except for <span class=""subject_text"">gout flares</span>, which were more frequent with febuxostat than with <span class=""object_text"">allopurinol</span>.</div>"	"&quot;<span class=""form_subject"">gout flares</span>&quot;"	"&quot;<span class=""form_object"">allopurinol</span>&quot;"
positive	18713852	12	headache	80	88	disease	posaconazole	59	71	drug	The most common adverse effects associated with the use of posaconazole include headache, fever, nausea, vomiting, and diarrhea.	"<div class=""formatted_sentence"">The most common adverse effects associated with the use of <span class=""object_text"">posaconazole</span> include <span class=""subject_text"">headache</span>, fever, nausea, vomiting, and diarrhea.</div>"	"&quot;<span class=""form_subject"">headache</span>&quot;"	"&quot;<span class=""form_object"">posaconazole</span>&quot;"
false	18586644	8	infections	171	181	disease	NaFe-EDTA	67	76	drug	No significant differences were observed between FeSO4+citrate and NaFe-EDTA fortification, regarding mitigation of iron-deficiency anemia (IDA) or regarding CRP, growth, infections, or side-effects.	"<div class=""formatted_sentence"">No significant differences were observed between FeSO4+citrate and <span class=""object_text"">NaFe-EDTA</span> fortification, regarding mitigation of iron-deficiency anemia (IDA) or regarding CRP, growth, <span class=""subject_text"">infections</span>, or side-effects.</div>"	"&quot;<span class=""form_subject"">infections</span>&quot;"	"&quot;<span class=""form_object"">NaFe-EDTA</span>&quot;"
positive	18434457	12	pain	114	118	disease	intravenous meperidine	129	151	drug	Intra-articular injection of lidocaine before closed reduction of anterior shoulder dislocation produces the same pain relief as intravenous meperidine and diazepam.	"<div class=""formatted_sentence"">Intra-articular injection of lidocaine before closed reduction of anterior shoulder dislocation produces the same <span class=""subject_text"">pain</span> relief as <span class=""object_text"">intravenous meperidine</span> and diazepam.</div>"	"&quot;<span class=""form_subject"">pain</span>&quot;"	"&quot;<span class=""form_object"">intravenous meperidine</span>&quot;"
false	18586644	8	iron-deficiency anemia	116	138	disease	FeSO4	49	54	drug	No significant differences were observed between FeSO4+citrate and NaFe-EDTA fortification, regarding mitigation of iron-deficiency anemia (IDA) or regarding CRP, growth, infections, or side-effects.	"<div class=""formatted_sentence"">No significant differences were observed between <span class=""object_text"">FeSO4</span>+citrate and NaFe-EDTA fortification, regarding mitigation of <span class=""subject_text"">iron-deficiency anemia</span> (IDA) or regarding CRP, growth, infections, or side-effects.</div>"	"&quot;<span class=""form_subject"">iron-deficiency anemia</span>&quot;"	"&quot;<span class=""form_object"">FeSO4</span>&quot;"
positive	19100448	12	severe diarrhea	191	206	disease	MMF	214	217	drug	We concluded that conversion to SRL in pancreas transplantation should be considered an important alternative strategy, particularly for CNI nephrotoxicity and neurotoxicity, and in cases of severe diarrhea due to MMF.	"<div class=""formatted_sentence"">We concluded that conversion to SRL in pancreas transplantation should be considered an important alternative strategy, particularly for CNI nephrotoxicity and neurotoxicity, and in cases of <span class=""subject_text"">severe diarrhea</span> due to <span class=""object_text"">MMF</span>.</div>"	"&quot;<span class=""form_subject"">severe diarrhea</span>&quot;"	"&quot;<span class=""form_object"">MMF</span>&quot;"
positive	17945482	8	lung cancer	213	224	disease	sutent	88	94	drug	Finally, in non-small cell lung cancer (NSCLC) in patients' progressing on chemotherapy sutent was able to achieve a 10% response rate, a level of activity similar to those documented by other agents approved for lung cancer.	"<div class=""formatted_sentence"">Finally, in non-small cell lung cancer (NSCLC) in patients' progressing on chemotherapy <span class=""object_text"">sutent</span> was able to achieve a 10% response rate, a level of activity similar to those documented by other agents approved for <span class=""subject_text"">lung cancer</span>.</div>"	"&quot;<span class=""form_subject"">lung cancer</span>&quot;"	"&quot;<span class=""form_object"">sutent</span>&quot;"
false	18300089	7	ocular inflammation	155	174	disease	alkylating agents	48	65	drug	Past use of antimetabolites, T-cell inhibitors, alkylating agents, and other immunosuppressives is ascertained from medical records of approximately 9,250 ocular inflammation patients at five tertiary centers over up to 30 years.	"<div class=""formatted_sentence"">Past use of antimetabolites, T-cell inhibitors, <span class=""object_text"">alkylating agents</span>, and other immunosuppressives is ascertained from medical records of approximately 9,250 <span class=""subject_text"">ocular inflammation</span> patients at five tertiary centers over up to 30 years.</div>"	"&quot;<span class=""form_subject"">ocular inflammation</span>&quot;"	"&quot;<span class=""form_object"">alkylating agents</span>&quot;"
false	18300089	11	ocular inflammation	103	122	disease	immunosuppressive drugs	75	98	drug	Information from the SITE Cohort Study should clarify whether use of these immunosuppressive drugs for ocular inflammation increases the risk of mortality and fatal cancer.	"<div class=""formatted_sentence"">Information from the SITE Cohort Study should clarify whether use of these <span class=""object_text"">immunosuppressive drugs</span> for <span class=""subject_text"">ocular inflammation</span> increases the risk of mortality and fatal cancer.</div>"	"&quot;<span class=""form_subject"">ocular inflammation</span>&quot;"	"&quot;<span class=""form_object"">immunosuppressive drugs</span>&quot;"
positive	18953065	12	leukoencephalopathy	115	134	disease	CCNU	55	59	drug	The combination of high-dose MTX with procarbazine and CCNU is feasible and effective and results in a low rate of leukoencephalopathy.	"<div class=""formatted_sentence"">The combination of high-dose MTX with procarbazine and <span class=""object_text"">CCNU</span> is feasible and effective and results in a low rate of <span class=""subject_text"">leukoencephalopathy</span>.</div>"	"&quot;<span class=""form_subject"">leukoencephalopathy</span>&quot;"	"&quot;<span class=""form_object"">CCNU</span>&quot;"
positive	17562245	1	high-grade non-Hodgkin lymphoma	179	210	disease	rituximab	36	45	drug	Administration of full-dose R-CHOP (rituximab/cyclophosphamide/doxorubicin/vincristine/prednisone) chemotherapy is important to maximize response in patients with intermediate-or high-grade non-Hodgkin lymphoma but might be difficult in older patients.	"<div class=""formatted_sentence"">Administration of full-dose R-CHOP (<span class=""object_text"">rituximab</span>/cyclophosphamide/doxorubicin/vincristine/prednisone) chemotherapy is important to maximize response in patients with intermediate-or <span class=""subject_text"">high-grade non-Hodgkin lymphoma</span> but might be difficult in older patients.</div>"	"&quot;<span class=""form_subject"">high-grade non-Hodgkin lymphoma</span>&quot;"	"&quot;<span class=""form_object"">rituximab</span>&quot;"
false	18300089	7	ocular inflammation	155	174	disease	T-cell inhibitors	29	46	drug	Past use of antimetabolites, T-cell inhibitors, alkylating agents, and other immunosuppressives is ascertained from medical records of approximately 9,250 ocular inflammation patients at five tertiary centers over up to 30 years.	"<div class=""formatted_sentence"">Past use of antimetabolites, <span class=""object_text"">T-cell inhibitors</span>, alkylating agents, and other immunosuppressives is ascertained from medical records of approximately 9,250 <span class=""subject_text"">ocular inflammation</span> patients at five tertiary centers over up to 30 years.</div>"	"&quot;<span class=""form_subject"">ocular inflammation</span>&quot;"	"&quot;<span class=""form_object"">T-cell inhibitors</span>&quot;"
positive	18371953	11	glioma	178	184	disease	indomethacin-loaded nanocapsules	93	125	drug	Another important finding was that the cytotoxic effect induced by 25 microM or 50 microM of indomethacin-loaded nanocapsules or indomethacin ethyl ester-loaded nanocapsules, in glioma cells was not observed in the organotypic cultures, indicating selective cytotoxicity of those formulations for tumoral cells.	"<div class=""formatted_sentence"">Another important finding was that the cytotoxic effect induced by 25 microM or 50 microM of <span class=""object_text"">indomethacin-loaded nanocapsules</span> or indomethacin ethyl ester-loaded nanocapsules, in <span class=""subject_text"">glioma</span> cells was not observed in the organotypic cultures, indicating selective cytotoxicity of those formulations for tumoral cells.</div>"	"&quot;<span class=""form_subject"">glioma</span>&quot;"	"&quot;<span class=""form_object"">indomethacin-loaded nanocapsules</span>&quot;"
positive	17989313	10	multiple myeloma	107	123	disease	BiRD	0	4	drug	BiRD is an effective regimen with manageable side effects in the treatment of symptomatic, newly diagnosed multiple myeloma.	"<div class=""formatted_sentence""><span class=""object_text"">BiRD</span> is an effective regimen with manageable side effects in the treatment of symptomatic, newly diagnosed <span class=""subject_text"">multiple myeloma</span>.</div>"	"&quot;<span class=""form_subject"">multiple myeloma</span>&quot;"	"&quot;<span class=""form_object"">BiRD</span>&quot;"
false	17340045	0	rheumatoid arthritis	49	69	disease	etanercept	30	40	drug	Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients.	"<div class=""formatted_sentence"">Development of sarcoidosis in <span class=""object_text"">etanercept</span>-treated <span class=""subject_text"">rheumatoid arthritis</span> patients.</div>"	"&quot;<span class=""form_subject"">rheumatoid arthritis</span>&quot;"	"&quot;<span class=""form_object"">etanercept</span>&quot;"
speculative	18452197	1	colitis-associated colorectal cancer	87	123	disease	5-ASA	64	69	drug	The impact of the antiinflammatory agent 5-aminosalicylic acid (5-ASA) on the risk for colitis-associated colorectal cancer remains controversial.	"<div class=""formatted_sentence"">The impact of the antiinflammatory agent 5-aminosalicylic acid (<span class=""object_text"">5-ASA</span>) on the risk for <span class=""subject_text"">colitis-associated colorectal cancer</span> remains controversial.</div>"	"&quot;<span class=""form_subject"">colitis-associated colorectal cancer</span>&quot;"	"&quot;<span class=""form_object"">5-ASA</span>&quot;"
false	17291222	3	chest pain	103	113	disease	SRL	27	30	drug	Two years after initiating SRL, she presented complaints of progressive dyspnoea, nonproductive cough, chest pain and low-grade fever of 1 month duration.	"<div class=""formatted_sentence"">Two years after initiating <span class=""object_text"">SRL</span>, she presented complaints of progressive dyspnoea, nonproductive cough, <span class=""subject_text"">chest pain</span> and low-grade fever of 1 month duration.</div>"	"&quot;<span class=""form_subject"">chest pain</span>&quot;"	"&quot;<span class=""form_object"">SRL</span>&quot;"
speculative	18452197	9	colonic neoplasms	179	196	disease	low-dose 5-ASA	24	38	drug	These data suggest that low-dose 5-ASA may be efficacious in preventing colitis-associated dysplasias and provide strong support for optimizing this therapy for the prevention of colonic neoplasms in patients with ulcerative colitis.	"<div class=""formatted_sentence"">These data suggest that <span class=""object_text"">low-dose 5-ASA</span> may be efficacious in preventing colitis-associated dysplasias and provide strong support for optimizing this therapy for the prevention of <span class=""subject_text"">colonic neoplasms</span> in patients with ulcerative colitis.</div>"	"&quot;<span class=""form_subject"">colonic neoplasms</span>&quot;"	"&quot;<span class=""form_object"">low-dose 5-ASA</span>&quot;"
positive	18713852	12	vomiting	105	113	disease	posaconazole	59	71	drug	The most common adverse effects associated with the use of posaconazole include headache, fever, nausea, vomiting, and diarrhea.	"<div class=""formatted_sentence"">The most common adverse effects associated with the use of <span class=""object_text"">posaconazole</span> include headache, fever, nausea, <span class=""subject_text"">vomiting</span>, and diarrhea.</div>"	"&quot;<span class=""form_subject"">vomiting</span>&quot;"	"&quot;<span class=""form_object"">posaconazole</span>&quot;"
positive	17945482	3	metastatic renal cell carcinoma	106	137	disease	sutent	35	41	drug	In several phase I/II/III studies, sutent was found to be effective as second and first line treatment in metastatic renal cell carcinoma (RCC).	"<div class=""formatted_sentence"">In several phase I/II/III studies, <span class=""object_text"">sutent</span> was found to be effective as second and first line treatment in <span class=""subject_text"">metastatic renal cell carcinoma</span> (RCC).</div>"	"&quot;<span class=""form_subject"">metastatic renal cell carcinoma</span>&quot;"	"&quot;<span class=""form_object"">sutent</span>&quot;"
false	17989313	0	multiple myeloma	173	189	disease	BiRD	0	4	drug	BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma.	"<div class=""formatted_sentence""><span class=""object_text"">BiRD</span> (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic <span class=""subject_text"">multiple myeloma</span>.</div>"	"&quot;<span class=""form_subject"">multiple myeloma</span>&quot;"	"&quot;<span class=""form_object"">BiRD</span>&quot;"
positive	19135998	7	anemia	79	85	disease	ribavirin	110	119	drug	Adverse events were similar across treatment groups except for higher rates of anemia in the groups receiving ribavirin.	"<div class=""formatted_sentence"">Adverse events were similar across treatment groups except for higher rates of <span class=""subject_text"">anemia</span> in the groups receiving <span class=""object_text"">ribavirin</span>.</div>"	"&quot;<span class=""form_subject"">anemia</span>&quot;"	"&quot;<span class=""form_object"">ribavirin</span>&quot;"
false	18512713	8	malignancy	42	52	disease	methotrexate	59	71	drug	There was an estimated 50% excess risk of malignancy among methotrexate-exposed RA patients relative to the general population (SIR 1.5, 95% confidence interval [95% CI] 1.2-1.9), with a 3-fold increase in melanoma (SIR 3.0, 95% CI 1.2-6.2), a 5-fold increase in non-Hodgkin's lymphoma (SIR 5.1, 95% CI 2.2-10.0), and an almost 3-fold increase in lung cancer (SIR 2.9, 95% CI 1.6-4.8).	"<div class=""formatted_sentence"">There was an estimated 50% excess risk of <span class=""subject_text"">malignancy</span> among <span class=""object_text"">methotrexate</span>-exposed RA patients relative to the general population (SIR 1.5, 95% confidence interval [95% CI] 1.2-1.9), with a 3-fold increase in melanoma (SIR 3.0, 95% CI 1.2-6.2), a 5-fold increase in non-Hodgkin's lymphoma (SIR 5.1, 95% CI 2.2-10.0), and an almost 3-fold increase in lung cancer (SIR 2.9, 95% CI 1.6-4.8).</div>"	"&quot;<span class=""form_subject"">malignancy</span>&quot;"	"&quot;<span class=""form_object"">methotrexate</span>&quot;"
false	17547473	7	cancer	212	218	disease	amlodipine	54	64	drug	Compared with both diuretics and contemporary agents, amlodipine decreases cardiovascular events to a similar or greater extent without evidence for increased coronary heart disease, gastrointestinal bleeding or cancer.	"<div class=""formatted_sentence"">Compared with both diuretics and contemporary agents, <span class=""object_text"">amlodipine</span> decreases cardiovascular events to a similar or greater extent without evidence for increased coronary heart disease, gastrointestinal bleeding or <span class=""subject_text"">cancer</span>.</div>"	"&quot;<span class=""form_subject"">cancer</span>&quot;"	"&quot;<span class=""form_object"">amlodipine</span>&quot;"
positive	17945482	5	GIST	101	105	disease	Sutent	0	6	drug	Sutent was also effective as second line treatment in patients with gastrointestinal stromal tumors (GIST) with 8% response rate, 70% stable disease and a 20-month median survival.	"<div class=""formatted_sentence""><span class=""object_text"">Sutent</span> was also effective as second line treatment in patients with gastrointestinal stromal tumors (<span class=""subject_text"">GIST</span>) with 8% response rate, 70% stable disease and a 20-month median survival.</div>"	"&quot;<span class=""form_subject"">GIST</span>&quot;"	"&quot;<span class=""form_object"">Sutent</span>&quot;"
positive	18975369	7	gout	186	190	disease	febuxostat	22	32	drug	At all doses studied, febuxostat more effectively lowered and maintained serum urate levels <6.0 mg/dl than did allopurinol (300 or 100 mg) or placebo in subjects with hyperuricemia and gout, including those with mild to moderately impaired renal function.	"<div class=""formatted_sentence"">At all doses studied, <span class=""object_text"">febuxostat</span> more effectively lowered and maintained serum urate levels <6.0 mg/dl than did allopurinol (300 or 100 mg) or placebo in subjects with hyperuricemia and <span class=""subject_text"">gout</span>, including those with mild to moderately impaired renal function.</div>"	"&quot;<span class=""form_subject"">gout</span>&quot;"	"&quot;<span class=""form_object"">febuxostat</span>&quot;"
false	18389682	2	thromboembolism	210	225	disease	anticoagulant	105	118	drug	Dental surgery for these children has historically consisted of decreasing and/or discontinuing the oral anticoagulant and instituting heparin therapy prior to the planned dental procedure, which can result in thromboembolism and increased morbidity and mortality.	"<div class=""formatted_sentence"">Dental surgery for these children has historically consisted of decreasing and/or discontinuing the oral <span class=""object_text"">anticoagulant</span> and instituting heparin therapy prior to the planned dental procedure, which can result in <span class=""subject_text"">thromboembolism</span> and increased morbidity and mortality.</div>"	"&quot;<span class=""form_subject"">thromboembolism</span>&quot;"	"&quot;<span class=""form_object"">anticoagulant</span>&quot;"
positive	18371953	10	glioma	136	142	disease	indomethacin-loaded nanocapsules	27	59	drug	Interestingly, 5 microM of indomethacin-loaded nanocapsules was able to cause an antiproliferative effect without promoting necrosis in glioma cells.	"<div class=""formatted_sentence"">Interestingly, 5 microM of <span class=""object_text"">indomethacin-loaded nanocapsules</span> was able to cause an antiproliferative effect without promoting necrosis in <span class=""subject_text"">glioma</span> cells.</div>"	"&quot;<span class=""form_subject"">glioma</span>&quot;"	"&quot;<span class=""form_object"">indomethacin-loaded nanocapsules</span>&quot;"
false	18452197	2	colitis-associated neoplasia	138	166	disease	azoxymethane	82	94	drug	The chemopreventive activity of 5-ASA was evaluated in the Swiss Webster model of azoxymethane (AOM)/dextran sulfate sodium (DSS)-induced colitis-associated neoplasia.	"<div class=""formatted_sentence"">The chemopreventive activity of 5-ASA was evaluated in the Swiss Webster model of <span class=""object_text"">azoxymethane</span> (AOM)/dextran sulfate sodium (DSS)-induced <span class=""subject_text"">colitis-associated neoplasia</span>.</div>"	"&quot;<span class=""form_subject"">colitis-associated neoplasia</span>&quot;"	"&quot;<span class=""form_object"">azoxymethane</span>&quot;"
positive	18220495	4	refractory schizophrenia	150	174	disease	clozapine	59	68	drug	Despite a higher incidence of adverse effects in children, clozapine appears to be a uniquely beneficial second-line agent for treating children with refractory schizophrenia.	"<div class=""formatted_sentence"">Despite a higher incidence of adverse effects in children, <span class=""object_text"">clozapine</span> appears to be a uniquely beneficial second-line agent for treating children with <span class=""subject_text"">refractory schizophrenia</span>.</div>"	"&quot;<span class=""form_subject"">refractory schizophrenia</span>&quot;"	"&quot;<span class=""form_object"">clozapine</span>&quot;"
positive	18713852	7	invasive fungal infections	69	95	disease	Posaconazole	0	12	drug	Posaconazole, in doses of 200 mg 3 times daily, reduced breakthrough invasive fungal infections (OR 0.30; 95% CI 0.12 to 0.71) and aspergillosis incidence (OR 0.31; 95% CI 0.13 to 0.75) in patients receiving hematopoietic stem-cell transplants compared with those receiving fluconazole.	"<div class=""formatted_sentence""><span class=""object_text"">Posaconazole</span>, in doses of 200 mg 3 times daily, reduced breakthrough <span class=""subject_text"">invasive fungal infections</span> (OR 0.30; 95% CI 0.12 to 0.71) and aspergillosis incidence (OR 0.31; 95% CI 0.13 to 0.75) in patients receiving hematopoietic stem-cell transplants compared with those receiving fluconazole.</div>"	"&quot;<span class=""form_subject"">invasive fungal infections</span>&quot;"	"&quot;<span class=""form_object"">Posaconazole</span>&quot;"
positive	18371953	0	glioma	96	102	disease	indomethacin	26	38	drug	Selective cytotoxicity of indomethacin and indomethacin ethyl ester-loaded nanocapsules against glioma cell lines: an in vitro study.	"<div class=""formatted_sentence"">Selective cytotoxicity of <span class=""object_text"">indomethacin</span> and indomethacin ethyl ester-loaded nanocapsules against <span class=""subject_text"">glioma</span> cell lines: an in vitro study.</div>"	"&quot;<span class=""form_subject"">glioma</span>&quot;"	"&quot;<span class=""form_object"">indomethacin</span>&quot;"
positive	18371953	9	glioma	22	28	disease	indomethacin ethyl ester-loaded nanocapsules	100	144	drug	In addition, when the glioma cells were exposed to 25 microM of indomethacin-loaded nanocapsules or indomethacin ethyl ester-loaded nanocapsules, a necrotic cell death was observed.	"<div class=""formatted_sentence"">In addition, when the <span class=""subject_text"">glioma</span> cells were exposed to 25 microM of indomethacin-loaded nanocapsules or <span class=""object_text"">indomethacin ethyl ester-loaded nanocapsules</span>, a necrotic cell death was observed.</div>"	"&quot;<span class=""form_subject"">glioma</span>&quot;"	"&quot;<span class=""form_object"">indomethacin ethyl ester-loaded nanocapsules</span>&quot;"
positive	17562245	1	high-grade non-Hodgkin lymphoma	179	210	disease	prednisone	87	97	drug	Administration of full-dose R-CHOP (rituximab/cyclophosphamide/doxorubicin/vincristine/prednisone) chemotherapy is important to maximize response in patients with intermediate-or high-grade non-Hodgkin lymphoma but might be difficult in older patients.	"<div class=""formatted_sentence"">Administration of full-dose R-CHOP (rituximab/cyclophosphamide/doxorubicin/vincristine/<span class=""object_text"">prednisone</span>) chemotherapy is important to maximize response in patients with intermediate-or <span class=""subject_text"">high-grade non-Hodgkin lymphoma</span> but might be difficult in older patients.</div>"	"&quot;<span class=""form_subject"">high-grade non-Hodgkin lymphoma</span>&quot;"	"&quot;<span class=""form_object"">prednisone</span>&quot;"
false	19135998	1	chronic hepatitis C genotype 4	88	118	disease	peginterferon	132	145	drug	Sustained virologic response (SVR) rates of 50%-60% have been achieved in patients with chronic hepatitis C genotype 4 treated with peginterferon plus ribavirin.	"<div class=""formatted_sentence"">Sustained virologic response (SVR) rates of 50%-60% have been achieved in patients with <span class=""subject_text"">chronic hepatitis C genotype 4</span> treated with <span class=""object_text"">peginterferon</span> plus ribavirin.</div>"	"&quot;<span class=""form_subject"">chronic hepatitis C genotype 4</span>&quot;"	"&quot;<span class=""form_object"">peginterferon</span>&quot;"
positive	17391803	0	advanced-stage non-small-cell lung cancer	59	100	disease	docetaxel	45	54	drug	An open multicenter phase II trial of weekly docetaxel for advanced-stage non-small-cell lung cancer in elderly patients with significant comorbidity and/or poor performance status: The GFPC 02-02b study.	"<div class=""formatted_sentence"">An open multicenter phase II trial of weekly <span class=""object_text"">docetaxel</span> for <span class=""subject_text"">advanced-stage non-small-cell lung cancer</span> in elderly patients with significant comorbidity and/or poor performance status: The GFPC 02-02b study.</div>"	"&quot;<span class=""form_subject"">advanced-stage non-small-cell lung cancer</span>&quot;"	"&quot;<span class=""form_object"">docetaxel</span>&quot;"
positive	17940253	3	spasticity	97	107	disease	botulinum toxin type B	113	135	drug	We describe the case of a 10-year-old boy who developed systemic weakness following treatment of spasticity with botulinum toxin type B.	"<div class=""formatted_sentence"">We describe the case of a 10-year-old boy who developed systemic weakness following treatment of <span class=""subject_text"">spasticity</span> with <span class=""object_text"">botulinum toxin type B</span>.</div>"	"&quot;<span class=""form_subject"">spasticity</span>&quot;"	"&quot;<span class=""form_object"">botulinum toxin type B</span>&quot;"
